The global oncology market is undergoing rapid growth, mainly due to the increasing number of cancer cases around the world. The World Health Organization estimates there will be over 35 million new ...

Fact checked by Vikki Velasquez More people need better medicines, and there is a rising demand for food and sustainable ...

OPKO Health strengthens finances by selling BioReference and focusing on drug development. Click here to read an analysis of ...

FN Media Group News Commentary - The global oncology market is undergoing rapid growth, mainly due to the increasing number of cancer cases around the world. The World Health Organization estimates ...

Access to healthcare should be guided by one principle: saving lives. Yet recently, trade tensions, tariffs and political ...

As President Donald Trump vows to bridge the drug pricing gap between the U.S. and other developed countries with his “most ...

Pfizer CEO Albert Bourla has pulled back the curtain on his $1.25 billion bet on a PD-1xVEGF bispecific, revealing that his ...

Following a landmark gathering of over 2,200 life sciences supply chain leaders in April, LogiPharma’s 25th anniversary ...

The global alpha-1 antitrypsin deficiency (AATD) market is expanding, driven by advances in diagnosis, treatment, and growing awareness. Key players ...

WPP has announced that CEO Mark Read will step down at the end of 2025, following a seven-year tenure marked by restructuring ...

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...